HLS Therapeutics CFO Tim Hendrickson Steps Down; Names Director John Hanna Interim CFO
(RTTNews) - Pharmaceutical company HLS Therapeutics Inc. (HLS.TO) announced Monday that Tim Hendrickson is stepping down as CFO to pursue other interests and John Hanna, currently a director of the Company, has been appointed Interim CFO.
Hendrickson will remain in his role until January 26, 2024, to support the transition and the Company will undertake a search for a permanent CFO in the new year.
While serving as Interim CFO, Hanna will remain on the HLS Board as a non-independent director
Hanna is an accomplished leader with more than 25 years of diverse experience, including in the healthcare industry. Previously, he served as CFO at Vecima Networks (VCM.TO), Inca Networks and eBuyNow and held a variety of senior financial roles with The Westaim Corp.
In addition to being a member of HLS's Board and the Audit Committee, Hanna has also served as a board member for a number of technology companies.
Kirkland Signature Ahi Tuna Wasabi Poke Sold At Costco Recalled
Bay Street Looks Headed For Positive Start
China's BYD Stock Down On Reports Of Warren Buffett's Berkshire Hathaway Sells Out Stake
FTSE 100 Up Marginally; Miners In Demand
CAC 40 Modestly Lower In Cautious Trade
DAX Moderately Lower; Auto Stocks Lose Ground
Sensex, Nifty End Lower As IT Stocks Plunge After Trump's H-1B Visa Fee Hike
